The Generic Drug Approval Process: A Complete Technical and Strategic Reference for Pharma IP, R&D, and Investment Teams
Generic drugs don’t “just happen.” Behind every approved ANDA sits a high-stakes, technically precise process that can make or break pharma IP strategy, R&D planning, and investment theses. If you’re an IP leader, R&D executive, or investor und…
